Skip to main content

Table 3 Accuracy of the different thresholds SSEP, EEG benign patterns, no myoclonus, NSE peak at day 3 < 60 µg/ml, and combinations for prediction of good outcome

From: SSEP N20 and P25 amplitudes predict poor and good neurologic outcomes after cardiac arrest

 

Se(%)

Sp(%)

FPR(%)

N20-baseline > 2 µV

39 (33–44)

73 (68–78)

27 (22–32)

N20-baseline > 2.7 µV

28 (23–33)

87 (83–91)

13 (9–17)

N20–P25 > 3,2 µV

29 (23–34)

93 (90–96)

7 (4–10)

N20–P25 > 4 µV

14 (10–18)

95 (92–97)

5.4 (3–8)

No status myoclonus

94 (92–97)

56 (51–62)

44 (38–49)

Day 3 NSE peak < 60 µg/ml

93 (90–96)

74.5 (69–80)

25.5 (20–31)

Benign EEG

89 (85–92)

86 (82–90)

14 (10–18)

N20-baseline > 2 µV + benign EEG

33.3 (28–39)

96.9 (95–99)

3.1 (1–5)

N20-baseline > 2 µV + NSE < 60 ng/ml

28 (23–33)

90.6 (87–94)

9.4 (6–13)

N20-baseline > 2 µV + no status myoclonus

33.3 (28–39)

86 (82–90)

14 (10–18)

N20–P25 > 3.2 µV + benign EEG

17 (13–21)

97 (93–98)

3 (2–7)

N20–P25 > 3.2 µV + day 3 NSE < 60 µg/ml

17 (13–21)

98.4 (97–100)

1.6 (0–3)

N20–P25 > 3.2 µV + No status myoclonus

17 (13–21)

95.3 (93–98)

4.7 (2–7)